China · Delayed Price · Currency is CNY Revance Therapeutics Statistics
Total Valuation
SHE:002035 has a market cap or net worth of CNY 5.34 billion. The enterprise value is 2.31 billion.
| Market Cap | 5.34B |
| Enterprise Value | 2.31B |
Important Dates
The next estimated earnings date is Saturday, August 30, 2025.
| Earnings Date | Aug 30, 2025 |
| Ex-Dividend Date | Jun 26, 2025 |
Share Statistics
SHE:002035 has 831.06 million shares outstanding. The number of shares has decreased by -1.62% in one year.
| Current Share Class | 831.06M |
| Shares Outstanding | 831.06M |
| Shares Change (YoY) | -1.62% |
| Shares Change (QoQ) | -0.04% |
| Owned by Insiders (%) | 14.99% |
| Owned by Institutions (%) | 16.99% |
| Float | 561.82M |
Valuation Ratios
The trailing PE ratio is 11.43 and the forward PE ratio is 10.11.
| PE Ratio | 11.43 |
| Forward PE | 10.11 |
| PS Ratio | 0.85 |
| PB Ratio | 1.36 |
| P/TBV Ratio | 1.54 |
| P/FCF Ratio | 18.15 |
| P/OCF Ratio | 8.98 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.34, with an EV/FCF ratio of 7.87.
| EV / Earnings | 4.95 |
| EV / Sales | 0.37 |
| EV / EBITDA | 4.34 |
| EV / EBIT | 5.30 |
| EV / FCF | 7.87 |
Financial Position
The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.54 |
| Quick Ratio | 1.31 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | 0.26 |
| Interest Coverage | 212.49 |
Financial Efficiency
Return on equity (ROE) is 12.18% and return on invested capital (ROIC) is 7.02%.
| Return on Equity (ROE) | 12.18% |
| Return on Assets (ROA) | 3.83% |
| Return on Invested Capital (ROIC) | 7.02% |
| Return on Capital Employed (ROCE) | 10.88% |
| Revenue Per Employee | 1.20M |
| Profits Per Employee | 89,706 |
| Employee Count | 5,205 |
| Asset Turnover | 0.88 |
| Inventory Turnover | 5.34 |
Taxes
In the past 12 months, SHE:002035 has paid 48.76 million in taxes.
| Income Tax | 48.76M |
| Effective Tax Rate | 9.48% |
Stock Price Statistics
The stock price has decreased by -2.43% in the last 52 weeks. The beta is 0.43, so SHE:002035's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | -2.43% |
| 50-Day Moving Average | 6.48 |
| 200-Day Moving Average | 7.11 |
| Relative Strength Index (RSI) | 44.99 |
| Average Volume (20 Days) | 10,150,495 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:002035 had revenue of CNY 6.25 billion and earned 466.92 million in profits. Earnings per share was 0.56.
| Revenue | 6.25B |
| Gross Profit | 2.48B |
| Operating Income | 436.30M |
| Pretax Income | 514.41M |
| Net Income | 466.92M |
| EBITDA | 530.17M |
| EBIT | 436.30M |
| Earnings Per Share (EPS) | 0.56 |
Balance Sheet
The company has 3.14 billion in cash and 75.42 million in debt, giving a net cash position of 3.07 billion or 3.69 per share.
| Cash & Cash Equivalents | 3.14B |
| Total Debt | 75.42M |
| Net Cash | 3.07B |
| Net Cash Per Share | 3.69 |
| Equity (Book Value) | 3.93B |
| Book Value Per Share | 4.68 |
| Working Capital | 1.74B |
Cash Flow
In the last 12 months, operating cash flow was 594.24 million and capital expenditures -300.29 million, giving a free cash flow of 293.95 million.
| Operating Cash Flow | 594.24M |
| Capital Expenditures | -300.29M |
| Free Cash Flow | 293.95M |
| FCF Per Share | 0.35 |
Margins
Gross margin is 39.66%, with operating and profit margins of 6.98% and 7.47%.
| Gross Margin | 39.66% |
| Operating Margin | 6.98% |
| Pretax Margin | 8.23% |
| Profit Margin | 7.47% |
| EBITDA Margin | 8.48% |
| EBIT Margin | 6.98% |
| FCF Margin | 4.70% |
Dividends & Yields
This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 4.68%.
| Dividend Per Share | 0.30 |
| Dividend Yield | 4.68% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 53.80% |
| Buyback Yield | 1.62% |
| Shareholder Yield | 6.30% |
| Earnings Yield | 8.75% |
| FCF Yield | 5.51% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 5, 2018. It was a forward split with a ratio of 1.5.
| Last Split Date | Jul 5, 2018 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
SHE:002035 has an Altman Z-Score of 3.04 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.04 |
| Piotroski F-Score | 5 |